The Incidence of Graves' Hyperthyroidism Before and After COVID-19 Messenger RNA Vaccination.

Endo, Mayumi; Pinto, Jessica; Roth, Mara Y; Hoofnagle, Andrew N; Failor, Richard A; Tylee, Tracy S

Endo, Mayumi; Pinto, Jessica; Roth, Mara Y; Hoofnagle, Andrew N; Failor, Richard A; Tylee, Tracy S.

Afiliação

Endo M; Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, Washington. Electronic address: mayendo@uw.edu.
Pinto J; Division of General Internal Medicine, University of Washington, Seattle, Washington.
Roth MY; Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, Washington.
Hoofnagle AN; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.
Failor RA; Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, Washington.
Tylee TS; Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, Washington.

Endocr Pract ; 29(8): 618-622, 2023 Aug.

Article em En | MEDLINE | ID: mdl-37391042

Assuntos

COVID-19; Doença de Graves; Hipertireoidismo; Humanos; Doença de Graves/epidemiologia; Doença de Graves/diagnóstico; Incidência; Vacinas contra COVID-19; COVID-19/epidemiologia; COVID-19/prevenção & controle; Hipertireoidismo/epidemiologia

Palavras-chave

COVID-19 mRNA vaccination; Graves' hyperthyroidism; autoimmune thyroid disease

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Graves / COVID-19 / Hipertireoidismo Tipo de estudo: Diagnostic_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Endocr Pract Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google